Pharmnovo Aktiebolag
Developing non-addictive delta opioid receptor agonists for neuropathic pain.
Overview
- 1–4
- Employees
- 10–20M SEK
- Revenue
- 2007
- Founded
Key Decision Makers
Karin Rosén
Member of the Board
Per von Mentzer
CEO
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
+2 more contacts in Funnelfeedr
Description
PharmNovo AB is a clinical-phase pharmaceutical company based in Lund, Sweden, focused on addressing the significant unmet medical need in chronic and neuropathic pain management. The company specializes in developing novel compounds based on selective delta opioid receptor agonists (DORAs). Their p...